Abstract:The mammalian gastrointestinal tract is colonized with a majority of gut microbes, affecting host metabolism and homeostasis. Gut microbiota plays a vital role in nutrient exchange, signaling transduction between intestinal epithelial cells, and resistance to pathogen invasion. Gut microbiota is divided into mucus layer bacteria and intestinal lumen bacteria based on the colonization distribution. Akkermansia muciniphila (A. muciniphila) prefers to colonize in the intestinal mucus layer, and specifically degrades mucins to produce short-chain fatty acids, providing energy for the host and promoting colonization of the bacterium itself. Degradation of mucins prompts the host to compensate for the production of more mucins, thereby maintaining the dynamics of these proteins. In the intestinal micro-ecosystem, A. muciniphila is non-pathogenic, and its colonization with suitable abundance contributes to the development of immune system, thus promoting intestinal health. The mechanisms by which A. muciniphila bears a protective role in the host intestine are currently unclear. In this review, we summarize the microenvironment for the colonization of A. muciniphila, physiological characteristics and pathophysiological impact of A. muciniphila on intestinal diseases, such as irritable bowel syndrome, inflammatory bowel diseases, and intestinal tumors. We also provided updates for current studies on signals that A. muciniphila enhances intestinal barrier integrity and regulates immune response. Together, we conclude that A. muciniphila is a promising probiotic, which could be a microbial target for the treatment of multiple intestinal diseases.

The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression

The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation

View from the Biological Property: Insight into the Functional Diversity and Complexity of the Gut Mucus

Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?

[Progress in the Role of Intestinal Goblet Cells in Intestinal Immune Regulation].

Roles of Side Chain Fucose of Mucin in Interaction between Intestinal Bacteria and Host

Health and Disease:Akkermansia Muciniphila,the Shining Star of the Gut Flora

Molecular regulation of the intestinal epithelial barrier: implication in human diseases.

A Critical Review on Intestinal Mucosal Barrier Protection Effects of Dietary Polysaccharides.

Mucins, gut microbiota, and postbiotics role in colorectal cancer

The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis

The role of mucin O-glycans in microbiota dysbiosis, intestinal homeostasis, and host-pathogen interactions

Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer

Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2

Critical Roles of Bile Acids in Regulating Intestinal Mucosal Immune Responses

Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases

Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies

The role of goblet cells and mucus in intestinal homeostasis

Mutual Interaction Between Gut Microbiota and Protein/amino Acid Metabolism for Host Mucosal Immunity and Health.

Clinicopathological Significance of Mucin 2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis

The Role of Iron in Intestinal Mucus: Perspectives from Both the Host and Gut Microbiota